HUTCHMED (LON:HCM) Shares Pass Above Two Hundred Day Moving Average – Here’s What Happened

HUTCHMED (China) Limited (LON:HCM)’s stock price crossed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 289.47 ($3.76) and traded as high as GBX 328 ($4.26). HUTCHMED shares last traded at GBX 323 ($4.19), with a volume of 192,043 shares traded.

HUTCHMED Price Performance

The company’s 50-day moving average price is GBX 279.26 and its 200-day moving average price is GBX 289.47. The company has a quick ratio of 2.97, a current ratio of 2.81 and a debt-to-equity ratio of 11.78. The firm has a market cap of £2.76 billion, a price-to-earnings ratio of -8,075.00 and a beta of 0.76.

HUTCHMED Company Profile

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in Hong Kong and internationally. The company develops Savolitinib for the treatment of non-small cell lung cancer (NSCLC), papillary renal cell carcinoma (RCC), and gastric cancer (GC); and Fruquintinib, an inhibitor for colorectal cancer (CRC), breast cancer, gastric cancer, microsatellite stable-CRC endometrial cancer (EMC), NSCLC, RCC, gastrointestinal, cervical, and solid tumors.